Brief: Sunesis Pharma Says William P. Quinn Provided Notice Of His Resignation As CFO
April 23 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS PHARMACEUTICALS - ON APRIL 20, WILLIAM P. QUINN
PROVIDED
NOTICE OF HIS RESIGNATION FROM HIS POSITIONS WITH CO AS CFO, ,
EFFECTIVE AS OF MAY 1
Source text: [https://bit.ly/3bAqWQm]
Further company coverage: SNSS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update